InnoVentures Capital Partners

Total investments

2

Average round size

7M

Portfolio companies

2

Rounds per year

0.08

Exits

1

Stages of investment
Debt
Areas of investment
BiotechnologyE-CommerceInternetHealth CareTherapeutics

Summary

InnoVentures Capital Partners is the famous VC, which was founded in 1996.

The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, LODH Immunology Fund, JapanWorks. In the next rounds fund is usually obtained by VI Partners AG, SV Health Investors, Novartis Venture Fund.

The higher amount of exits for fund were in 2009. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2002.

We can highlight the next thriving fund investment areas, such as Internet, Health Care. Among the various public portfolio startups of the fund, we may underline ESBATech Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
2
Lead investments
0
Exits
1
Rounds per year
0.08
Investments by industry
  • Therapeutics (1)
  • Biotechnology (1)
  • Health Care (1)
  • Internet (1)
  • E-Commerce (1)
Investments by region
  • Switzerland (1)
  • United States (1)
Peak activity year
2002

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
34
Avg. valuation at time of investment
294M
Group Appearance index
1.00
Avg. company exit year
11
Avg. multiplicator
9.35
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ESBATech 14 May 2002 Biotechnology, Health Care, Therapeutics Early Stage Venture 15M Switzerland, Zurich

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.